HIGHLIGHTS
- who: November et al. from the University of Giessen, Germany have published the research work: Clinical and molecular characteristics of a novel rare de novo variant in in a patient with a developmental disorder, autism, and epilepsy, in the Journal: (JOURNAL)
- what: If the experiment required the measurement of phosphatase activity, Tris buffered saline (TBS) was used instead of PBS, and phosphatase inhibitors were omitted from the lysis buffer. The female teenager the authors report here fell well within this spectrum, albeit, clearly, at the milder end.
- how: Statistical analysis of biochemical data . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.